This topic contains a solution. Click here to go to the answer

Author Question: Instead of making one pretest and one posttest measure, the ____________________ makes a longer ... (Read 24 times)

futuristic

  • Hero Member
  • *****
  • Posts: 638
Instead of making one pretest and one posttest measure, the ___________________ _ makes a longer series of observations before and after introducing an experimental treatment.
 
  Fill in the blank(s) with correct word

Question 2

When random assignment to experimental and control groups is not possible the researcher may be forced to use a(n) ___________________ _ design.
 
  Fill in the blank(s) with correct word



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bookworm410

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

interrupted time-series design

Answer to Question 2

nonequivalent-group




futuristic

  • Member
  • Posts: 638
Reply 2 on: Aug 13, 2018
:D TYSM


EAN94

  • Member
  • Posts: 307
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Only one in 10 cancer deaths is caused by the primary tumor. The vast majority of cancer mortality is caused by cells breaking away from the main tumor and metastasizing to other parts of the body, such as the brain, bones, or liver.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

There are more bacteria in your mouth than there are people in the world.

Did you know?

Though methadone is often used to treat dependency on other opioids, the drug itself can be abused. Crushing or snorting methadone can achieve the opiate "rush" desired by addicts. Improper use such as these can lead to a dangerous dependency on methadone. This drug now accounts for nearly one-third of opioid-related deaths.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library